The Palo Alto-based company makes the AeroForm tissue expander for post-mastectomy breast reconstruction. The device is designed to expand and stretch the skin and underlying muscle prior to a permanent breast implant using small amounts of CO2 up to three times a day.
The company said that it retained Cowen as its advisor, and that it is looking to explore financial and strategic alternatives.
Options under consideration include a capital raise, the company said in a press release, which it claims could enhance stockholder value and “enable the Company to continue serving other important constituencies, including patients and physicians.”
Last month, AirXpanders released results from a clinical study of its AeroForm system indicating that it’s use may be associated with reduced infection rates, less medical treatment and lower costs for patients and health systems.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!